Girish Rao
Company: Eli Lilly
Job title: Executive Director, Clinical Design- Cardiometabolic Health, Clinical Design Delivery & Analytics
Seminars:
3:45 pm Panel Discussion: Expanding GLP1’s Role to Target MASH-Related Comorbidities to Improve Holistic Patient Outcomes 3:45 pm
Detailing GLP-1s effects on comorbidities to illustrate how these drugs can address a range of MASH-related comorbidities to offer a comprehensive treatment strategy to improve overall patient management Highlighting the benefits of a holistic approach to understand the advantages of using GLP-1s to manage MASH and its associated conditions to lead to better coordination of…Read more
day: Conf day 2
10:15 am Making MASH a Strategic & Commercial Priority to Advance Next-Gen Therapies for More Effective Drug Development 10:15 am
Addressing the MASH opportunity to emphasize the crucial role of synergistic novel scientific approaches and strategic collaborative partnerships to drive the development of the next generation of effective therapies Prioritizing a review for next-generation therapies to understand the most promising emerging therapeutic avenues, including cell-based therapies and combination approaches, to strategically advance the future of…Read more
day: Conf Day 1